Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Clinical trial NCT01129557 · TERMINATED

Trial details

NCT number: NCT01129557
Sponsor: Columbia University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Proteinuric Kidney Disease Diabetic Nephropathy Hypertensive Nephrosclerosis IgA Nephropathy Focal Segmental Glomerulosclerosis Glomerulopathy (Obesity-associated)Glomerulonephritis, Membranous

Start date: 2009-09-01
Primary completion: 2012-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.